Tommy Flaishans

We’ve helped med-tech and med-device companies land $30M+ in federal contracts—often in under 6 months—using a white-glove strategy that turns data into action and immediate wins. Here’s a hard truth: Having data ≠ knowing what to do with it. We bring you: Not just lists, but real decision-maker intel. Know your targets by name. Not just usage data, but pricing intel down to what your competitors are charging. Not just access, but targeted federal engagement that drives results including Federal Health IT validation and certifcations such as FIPS-140 and FedRAMP Most data providers hand you a platform or spreadsheet and wish you luck. We’re not most.

At Peptide Provisions, our inner nerd has officially taken the wheel, driving us headfirst into the fascinating world of peptide research! Founded by Dr. Tommy Flaishans, MBA, Peptide Provisions is a biotech research firm dedicated to unlocking the immense potential of peptides to address critical health challenges. Drawing upon a unique blend of scientific rigor, strategic acumen, and a deep understanding of health policy, Peptide Provisions is committed to: - Conducting cutting-edge research: We are focused on exploring novel applications of peptides across a range of therapeutic areas. - Driving scientific innovation: Our approach is rooted in intellectual curiosity and a commitment to pushing the boundaries of scientific discovery. - Bridging the gap between science and policy: We understand the importance of translating research breakthroughs into tangible solutions that can impact human health. While our journey is just beginning, our passion for peptide science and our dedication to research are unwavering. https://peptideprovisions.com/pp/peptides

Experienced Healthcare Educator with a focus on macro trends and change in the industry. Expertise in CIPP/US, data protection, commercial strategy, healthcare policy, supply chain, product development process, process improvement, quantitative market research, demographics, leadership, cost analysis, product launch, and global health.

- Chair, Fundraising and Development Subcommittee

Spearheading upstream and downstream business development and our PatiotPro direct-to-government collaboration initiatives in the federal healthcare marketplace.

Manage a portfolio of top-tier global medical technology/device accounts, driving the customer retention and revenue growth of existing engagements and facilitating the adoption of all Definitive Healthcare SaaS product lines to transform data, analytics, and expertise into commercial healthcare intelligence across the enterprise to uncover the right markets, opportunities, and people so they can shape tomorrow’s healthcare industry.

Recruited to establish and lead the Health-IT team during an acquisition, with a focus on deploying, implementing Explorer as a SaaS solution and assessing cybersecurity risks for hospitals, pharmaceutical, and medical device companies.

In charge of setting up operations in the Americas, increasing sales of artificial intelligence and machine learning, SaaS products, and ensuring customer satisfaction in a new digital experience market. Acted as a crucial representative of the company in health-IT business partnering gatherings with large healthcare networks, life-science companies, and government agencies. ● Conceived and executed plans to build sales teams, increase sales, manage projects, and support teams in North and South America, resulting in 284 new deployments with Med-tech companies and securing $39million in Series B funding in 10 months. ● Directed global coordination with health-economic experts to revolutionize surgical telehealth adoption, digital transformation, robotics/surgical virtual training, and reimbursement.

Since the company’s founding in 1919, Olympus has been renowned as a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. In the healthcare arena, Olympus supports the work of medical professionals by providing advanced, minimally invasive therapeutic and diagnostic technologies to improve the quality of patient care around the globe.

PENTAX Medical is a division of HOYA Group delivering endo-imaging solutions. Established in 1919 in Japan, PENTAX Medical is a globally diversified company with R&D innovation and manufacturing centers in Japan, Europe and the United States. Through leading-edge optical technologies, PENTAX Medical is providing the most advanced clinically relevant endo-imaging solutions. Together with comprehensive customer service offerings, PENTAX Medical is collaborating with customers worldwide to create long-term partnerships and customer satisfaction.

When it really matters, the people, products, and services that Coram provides can have a lasting positive impact on our patients' lives. As an industry leader and the infusion provider of CVS, Coram cares for patients through a national network of 90+ locations, including 70+ infusion suites nationwide. Coram provides infusion therapies and services to more than 45,000 patients each month, supporting care through all phases of their healthcare continuum.

The DHA curriculum consists of 54 semester hours: 36 semester hours of core course work and 18 semester hours of doctoral project work. Course topics include financial management, health policy, strategic management, leadership, quality improvement, applied research, healthcare information resources, logical thinking and analysis, and topics in health administration leadership. The curriculum features four clusters of skill areas, each of which requires its own progressive ladder of competency development: Leadership Applied Research Health Policy Strategic Management oriented toward quality improvement and change management

-Accelerated, dual-degree MBA/MHA

• A.C.E. Personal Training Certification • National Coaching Certification